Ontology highlight
ABSTRACT: Background
Drugs used to treat rheumatic disease are associated with pneumotoxicity (drug-induced lung disease), but little is known about associated risk factors.Aim
To determine expert physician-perceived risk factors for developing pneumotoxicity in patients with rheumatologic conditions.Methods
A modified international 3-tier Delphi exercise was performed. Tier 1 determined patient and drug variables that physicians perceive to be risk factors. Tier 2 determined degree of risk associated with the Tier-1 derived variables. Tier 3 aimed to internally validate and stratify exemplar cases into risk categories.Results
134 pulmonologists and 49 rheumatologists responded to Tier 1;157 physicians completed all tiers. Perceived risk factors included: drug type; h
SUBMITTER: Cartlidge MK
PROVIDER: S-EPMC11529426 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature